James Putz

Sr. Director, Quality Control at Stemline Therapeutics Inc - New York, NY, US

James Putz's Contact Details
HQ
646-502-2310
Location
Company
Stemline Therapeutics Inc
James Putz's Company Details
Stemline Therapeutics Inc logo, Stemline Therapeutics Inc contact details

Stemline Therapeutics Inc

New York, NY, US • 100 - 249 Employees
BioTech/Drugs

Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with cancer.ELZONRIS a targeted therapy directed to CD123, is FDA-approved and commercially available in the U.S. for the treatment of adult and pediatric patients, two years and older, with BPDCN. In Europe, a marketing authorization application (MAA) is under review by the European Medicines Agency (EMA).Inspired by the goal to improve outcomes for patients with unmet medical needs, Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer. Currently our clinical-stage product candidates in include ELZONRIS, SL-701 and SL801.

B2B Biotechnology Healthcare Marketing Medical Diagnostics Pharmaceuticals BioTech/Drugs Commercial Physical Research
Details about Stemline Therapeutics Inc
Frequently Asked Questions about James Putz
James Putz currently works for Stemline Therapeutics, Inc.
James Putz's role at Stemline Therapeutics, Inc is Sr. Director, Quality Control.
James Putz's email address is ***@stemline.com. To view James Putz's full email address, please signup to ConnectPlex.
James Putz works in the Biotechnology industry.
James Putz's colleagues at Stemline Therapeutics Inc are Danielle Schubert, Ahmed Rabie, Roger Arguello, Lawrence Spencer, Christine Rivero, Allison Morin, Anjie Antommarchi and others.
James Putz's phone number is ["+12158225191"]
See more information about James Putz